This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rhizen Pharmaceuticals Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Babu Govindarajulu: Innovator in Kinase Inhibition
Introduction
Babu Govindarajulu is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel inhibitors for kinase-mediated diseases.
Latest Patents
Babu holds a patent for "Purine derivatives as SIK-3 inhibitors." This invention relates to innovative inhibitors of salt-inducible kinase-3 (SIK3). The patent outlines methods for preparing these inhibitors, pharmaceutical compositions containing them, and their application in treating or preventing kinase-mediated diseases or disorders.
Career Highlights
Babu Govindarajulu is currently associated with Rhizen Pharmaceuticals AG, where he continues to advance his research in kinase inhibition. His work is pivotal in the development of new therapeutic strategies for various diseases.
Collaborations
Babu collaborates with esteemed colleagues such as Prashant K Bhavar and Srikant Viswanadha, contributing to a dynamic research environment that fosters innovation.
Conclusion
Babu Govindarajulu's work in developing SIK-3 inhibitors showcases his commitment to advancing medical science. His contributions are vital for the future of treatments for kinase-mediated disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile